These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 8337030

  • 1. Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease.
    Parini R, Sereni LP, Bagozzi DC, Corbetta C, Rabier D, Narcy C, Hubert P, Saudubray JM.
    Pediatrics; 1993 Aug; 92(2):280-3. PubMed ID: 8337030
    [No Abstract] [Full Text] [Related]

  • 2. Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease.
    Berry GT, Heidenreich R, Kaplan P, Levine F, Mazur A, Palmieri MJ, Yudkoff M, Segal S.
    N Engl J Med; 1991 Jan 17; 324(3):175-9. PubMed ID: 1898534
    [No Abstract] [Full Text] [Related]

  • 3. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE, Goldstein F, Sansaricq C, Norton PM.
    Pediatr Res; 1984 Sep 17; 18(9):851-3. PubMed ID: 6483508
    [Abstract] [Full Text] [Related]

  • 4. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R, Srisomsap C, Wasant P, Svasti J, Suthatvoravut U, Chokchaichamnankit D, Liammongkolkul S.
    Southeast Asian J Trop Med Public Health; 1999 Sep 17; 30 Suppl 2():138-9. PubMed ID: 11400750
    [Abstract] [Full Text] [Related]

  • 5. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM, Rezvani I, Garibaldi LR, Schwartz M.
    N Engl J Med; 1982 Dec 09; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract] [Full Text] [Related]

  • 6. Utility of hemodialysis in maple syrup urine disease.
    Puliyanda DP, Harmon WE, Peterschmitt MJ, Irons M, Somers MJ.
    Pediatr Nephrol; 2002 Apr 09; 17(4):239-42. PubMed ID: 11956873
    [Abstract] [Full Text] [Related]

  • 7. [Simple and rapid determination of leucine by HPLC. Importance for extra-renal treatment of maple syrup urine disease].
    Garcia J, Galinier A, Periquet B, Broué P, Decramer S, Thouvenot JP, Caspar-Bauguil S.
    Ann Biol Clin (Paris); 2002 Apr 09; 60(5):602-6. PubMed ID: 12368147
    [No Abstract] [Full Text] [Related]

  • 8. Branched-chain alpha-keto acids for the diagnosis of maple-syrup-urine disease.
    Parsons H, Fung E, Snyder FF.
    N Engl J Med; 1987 Apr 09; 316(15):951. PubMed ID: 3821846
    [No Abstract] [Full Text] [Related]

  • 9. [Hemofiltration in acute neonatal metabolic crisis].
    Ring E, Zobel G.
    Wien Klin Wochenschr; 1992 Apr 09; 104(21):674-7. PubMed ID: 1475972
    [Abstract] [Full Text] [Related]

  • 10. Exfoliative erythroderma resulting from inadequate intake of branched-chain amino acids in infants with maple syrup urine disease.
    Northrup H, Sigman ES, Hebert AA.
    Arch Dermatol; 1993 Mar 09; 129(3):384-5. PubMed ID: 8447687
    [No Abstract] [Full Text] [Related]

  • 11. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y, MacDonnell RC.
    Adv Perit Dial; 1990 Mar 09; 6():31-4. PubMed ID: 1982835
    [Abstract] [Full Text] [Related]

  • 12. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P, Jugie M, Rabier D, Desgrès J, Hubert P, Saudubray JM, Man NK.
    Intensive Care Med; 2001 Nov 09; 27(11):1798-806. PubMed ID: 11810125
    [Abstract] [Full Text] [Related]

  • 13. Detection of maple syrup urine disease on resin coated chromatosheets.
    Kovács J.
    Acta Biochim Biophys Acad Sci Hung; 1979 Nov 09; 14(3):119-21. PubMed ID: 547666
    [No Abstract] [Full Text] [Related]

  • 14. Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease.
    Schuchmann L, Witt I, Schulz P, Schumacher H, Rüdiger H.
    Helv Paediatr Acta; 1972 Sep 09; 27(4):449-56. PubMed ID: 4644280
    [No Abstract] [Full Text] [Related]

  • 15. Maple syrup urine disease in Thai infants.
    Pangkanon S, Charoensiriwatana W, Sangtawesin V.
    J Med Assoc Thai; 2008 Oct 09; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [Abstract] [Full Text] [Related]

  • 16. The utility of dried blood spot monitoring of branched-chain amino acids for maple syrup urine disease: A retrospective chart review study.
    Kaur J, Nagy L, Wan B, Saleh H, Schulze A, Raiman J, Inbar-Feigenberg M.
    Clin Chim Acta; 2020 Jan 09; 500():195-201. PubMed ID: 31678570
    [Abstract] [Full Text] [Related]

  • 17. [Maple syrup urine disease and cystathioninemia].
    Simma B, Sperl W, Berger H.
    Padiatr Padol; 1989 Jan 09; 24(1):69-75. PubMed ID: 2497426
    [Abstract] [Full Text] [Related]

  • 18. Maple-syrup-urine disease.
    Wendel U, Lombeck I, Bremer HJ.
    N Engl J Med; 1983 May 05; 308(18):1100-1. PubMed ID: 6835327
    [No Abstract] [Full Text] [Related]

  • 19. Implications of Maple Syrup Urine Disease in Newborns.
    Harris-Haman P, Brown L, Massey S, Ramamoorthy S.
    Nurs Womens Health; 2017 May 05; 21(3):196-206. PubMed ID: 28599741
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K, Schwahn B, Marquardt I, Grotzke M, Wendel U.
    Mol Genet Metab; 2005 Apr 05; 84(4):313-6. PubMed ID: 15781191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.